相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis
Paolo Comeglio et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension
Linda Vignozzi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis
Yuji Sakuma
PATHOLOGY INTERNATIONAL (2017)
Severe idiopathic pulmonary fibrosis: what can be done?
Antonella Caminati et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history
Giacomo Sgalla et al.
RESPIROLOGY (2016)
Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Adam J. Byrne et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Sonsoles Piera-Velazquez et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1
Peter J. Wermuth et al.
PLOS ONE (2016)
Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Benoit Ranchoux et al.
CIRCULATION (2015)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Pulmonary Epithelial Cell-Derived Cytokine TGF-β1 Is a Critical Cofactor for Enhanced Innate Lymphoid Cell Function
Laura Denney et al.
IMMUNITY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Veronica Della Latta et al.
PHARMACOLOGICAL RESEARCH (2015)
Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
P. Spagnolo et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells
Siobhan M. Hendrick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: An experimental study in the rabbit
Linda Vignozzi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Strategies for anti-fibrotic therapies
Joel Rosenbloom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system
A. S. Ahmedat et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
FXR Protects Lung from Lipopolysaccharide-Induced Acute Injury
Lisheng Zhang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Prevention of Bleomycin-Induced Lung Fibrosis in Mice by a Novel Approach of Parallel Inhibition of Cyclooxygenase and Nitric-Oxide Donation Using NCX 466, a Prototype Cyclooxygenase Inhibitor and Nitric-Oxide Donor
Alessandro Pini et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Modeling pulmonary fibrosis with bleomycin
Marios A. Mouratis et al.
CURRENT OPINION IN PULMONARY MEDICINE (2011)
SERIES MATRIX METALLOPROTEINASES IN LUNG HEALTH AND DISEASE Metalloproteinases in idiopathic pulmonary fibrosis
R. C. A. Dancer et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis
Min Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes
Linda Vignozzi et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
The rising incidence of idiopathic pulmonary fibrosis in the UK
V. Navaratnam et al.
THORAX (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction
Dmitri V. Pechkovsky et al.
CLINICAL IMMUNOLOGY (2010)
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
Xiaoxin X. Wang et al.
DIABETES (2010)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type a receptor-mediated production of TGF-β1
Raksha Jain et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic
E Masini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) -: art. no. 56
H Kasai et al.
RESPIRATORY RESEARCH (2005)
Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis
A Xaubet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors
V Bolós et al.
JOURNAL OF CELL SCIENCE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II) in idiopathic pulmonary fibrosis
N Khalil et al.
THORAX (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
